| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |